Cold and flu medications are among around 2,000 products being recalled by the U.S. Food & Drug Administration over rat feces ...

Bengals coach fumes over referees' decision to stop play after Myles Garrett's record-breaking sack Zohran Mamdani asked Lucy ...

Biden opted not to press the Department of Justice for the release of the Epstein files amid Harris' presidential campaign against Donald Trump Tasos Katopodis/Getty Former Vice President Kamala ...

Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the FDA for approval on Thursday. Eli Lilly’s LLY drug is called orforglipron.

Novo Nordisk A/S (NYSE: NVO) on Thursday submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for once-weekly CagriSema. The application covers CagriSema for use with ...

Novo Nordisk NOVO.B1.08%increase; green up pointing triangle filed for U.S. Food and Drug Administration approval of CagriSema, a once-weekly shot that combines two compounds to treat obesity.

(RTTNews) - Organogenesis Holdings Inc. (ORGO) announced the successful completion of a planned Type-B meeting with the U.S. FDA, confirming that the company may initiate a rolling Biologics License ...

In a November memo, Vinay Prasad, MD, MPH, the FDA's top vaccine regulator, told his colleagues that the agency's "career staff have found that at least 10 children have died after and because of ...

FILE: Mifepristone tablets are seen in a Planned Parenthood clinic, July 18, 2024, in Ames, Iowa. TALLAHASSEE — Florida and Texas have filed a lawsuit challenging more than two decades of ...

Note that some links may require registration or subscription. The FDA reportedly told drugmakers that approved monoclonal antibodies to protect infants against respiratory syncytial virus (RSV) would ...

CHICAGO, Dec. 8, 2025 /PRNewswire/ -- Professor Sarfaraz K. Niazi, Ph.D., a leading authority in pharmaceutical sciences and internationally recognized biosimilars expert, has filed a major Citizen ...

uniQure N.V. (NASDAQ: QURE) stock is trading lower on Thursday. • QURE shares are retreating from recent levels. Check the market position here. The gene therapy company received final meeting minutes ...